Literature DB >> 7956900

Conversion of estrone to 2- and 4-hydroxyestrone by hamster kidney and liver microsomes: implications for the mechanism of estrogen-induced carcinogenesis.

B T Zhu1, Q D Bui, J Weisz, J G Liehr.   

Abstract

As part of an ongoing investigation of the role of metabolic activation of estrogens in the genesis of cancers such as estrogen-induced renal tumors in hamsters, we have 1) determined steroid-17 beta-oxidoreductase activity of microsomes and cytosol prepared from hamster kidney and liver; 2) compared the rates of 2-, 4-, and 16 alpha-hydroxylations of estrone by microsomes from hamster kidney and liver; and 3) determined the rates of inactivation of 2- and 4-hydroxyestrone by catechol-O-methyltransferase from hamster kidney and by purified enzyme. Microsomal steroid-17 beta-oxidoreductase activity in hamster kidney and liver was low and favored the conversion of estrone to estradiol. Cytosolic steroid-17 beta-oxidoreductase activity was only barely detectable in both liver and kidney. Using hepatic microsomes, the rate of 2-hydroxylation of estrone was comparable to that found previously using estradiol as substrate, whereas 4-hydroxylation of estrone was double that of estradiol. Using renal microsomes, the rates of 2- and 4-hydroxylation of estrone were 10- to 20-fold higher than those with estradiol as substrate, and the ratio of 2- to 4-hydroxylation was about 2:1. Fadrozole hydrochloride was an equally good inhibitor of rates of 2- and 4-hydroxylation of estrone (20 microM) by hepatic microsomes (IC50, approximately 25 microM). Corresponding IC50 values with renal microsomes were less than 2 microM, and 2-hydroxylation of estrone was inhibited by Fadrozole hydrochloride up to 15% more than 4-hydroxylation. Treatment of hamsters with estradiol for 2 months decreased rates of 2- and 4-hydroxylation of estrone by renal microsomes by approximately 95%. The rate of conversion of estrone to 16 alpha-hydroxyestrone by hepatic microsomes was 10-20% that of 2-hydroxylation. Renal microsomes catalyzed 16 alpha-hydroxylation of estrone at an even lower rate (approximately 5% of that of 2-hydroxylation). Rates of O-methylation of 2- and 4-hydroxyestrone by hamster kidney cytosol were comparable to those of 2- and 4-hydroxyestradiol. In conclusion, conversion of estrone to its catechol metabolites by microsomes of hamster kidney, a target organ of estrogen-induced carcinogenesis, is quantitatively more important than the conversion to 16 alpha-hydroxyestrone. The findings are consistent with the postulated role of catechol estrogens generated in situ in estrone-induced carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7956900     DOI: 10.1210/endo.135.5.7956900

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

Review 1.  The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.

Authors:  Maryann Kwa; Claudia S Plottel; Martin J Blaser; Sylvia Adams
Journal:  J Natl Cancer Inst       Date:  2016-04-22       Impact factor: 13.506

2.  Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators.

Authors:  E L Cavalieri; D E Stack; P D Devanesan; R Todorovic; I Dwivedy; S Higginbotham; S L Johansson; K D Patil; M L Gross; J K Gooden; R Ramanathan; R L Cerny; E G Rogan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

3.  Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats.

Authors:  Sarah M Mense; Bhupendra Singh; Fabrizio Remotti; Xinhua Liu; Hari K Bhat
Journal:  Carcinogenesis       Date:  2009-04-30       Impact factor: 4.944

4.  In the rat, estrone sulphate is the main serum metabolite of oral oleoyl-estrone.

Authors:  C Cabot; D González-Martínez; J-A Fernández-López; M Alemany
Journal:  J Endocrinol Invest       Date:  2007-05       Impact factor: 4.256

5.  SERMs attenuate estrogen-induced malignant transformation of human mammary epithelial cells by upregulating detoxification of oxidative metabolites.

Authors:  L P Madhubhani P Hemachandra; Hitisha Patel; R Esala P Chandrasena; Jaewoo Choi; Sujeewa C Piyankarage; Shuai Wang; Yijin Wang; Emily N Thayer; Robert A Scism; Bradley T Michalsen; Rui Xiong; Marton I Siklos; Judy L Bolton; Gregory R J Thatcher
Journal:  Cancer Prev Res (Phila)       Date:  2014-03-05

6.  Raloxifene and desmethylarzoxifene block estrogen-induced malignant transformation of human breast epithelial cells.

Authors:  Irida Kastrati; Praneeth D Edirisinghe; L-P-Madhubani P Hemachandra; Esala R Chandrasena; Jaewoo Choi; Yue-Ting Wang; Judy L Bolton; Gregory R J Thatcher
Journal:  PLoS One       Date:  2011-11-29       Impact factor: 3.240

Review 7.  Estradiol metabolism: an endocrine biomarker for modulation of human mammary carcinogenesis.

Authors:  N T Telang; M Katdare; H L Bradlow; M P Osborne
Journal:  Environ Health Perspect       Date:  1997-04       Impact factor: 9.031

Review 8.  The Microbiome-Estrogen Connection and Breast Cancer Risk.

Authors:  Sheetal Parida; Dipali Sharma
Journal:  Cells       Date:  2019-12-15       Impact factor: 6.600

9.  Effects of pesticides on the ratio of 16 alpha/2-hydroxyestrone: a biologic marker of breast cancer risk.

Authors:  H L Bradlow; D L Davis; G Lin; D Sepkovic; R Tiwari
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.